MedPath

Esophageal cancer treatment and outcome study

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: null- Esophageal cancer patients
Registration Number
CTRI/2015/09/006210
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
3000
Inclusion Criteria

1.All patients diagnosed with esophageal cancer presenting to the thoracic disease management group.

2.Patients willing to give written informed consent.

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Audit of esophageal cancer patients and record their demographic, clinical and pathological features.Timepoint: will assess every 3 months then restaging will be done and again after 6 months
Secondary Outcome Measures
NameTimeMethod
1.Collation of information on clinical course of the disease, treatment and after therapy follow-up. <br/ ><br>2.To promote collaborative research. <br/ ><br>Timepoint: at 3 months, At Progression and at death
© Copyright 2025. All Rights Reserved by MedPath